AMR Projected to Cause over 10m Deaths Globally by 2050 – NCDC
The Nigeria Centre for Disease Control and Prevention (NCDC) says Antimicrobial Resistance (AMR) is a silent and slow epidemic that does not produce the waves and peaks seen by the world in the past years during the COVID-19 pandemic.
During a briefing commemoratimg the 2022 Antibiotics Awareness Week in Abuja, the Director-General of the NCDC, Dr Ifedayo Adetifa, said that “AMR is a serious threat”.
“It affects us all. This is why this year’s theme calls for collaboration across sectors to preserve the efficacy of these critical medicines.
“Fighting AMR is a truly global endeavour and must be addressed through a One Health Approach.”
Adetifa, who was represented by the Chair of the National Antimicrobial Resistance Coordination Committee (NAMRCC), Dr Tochi Okwor, described AMR as a pandemic waiting to happen.
He stated that in Nigeria, seven out of 10 persons in the community accessed antibiotics outside licensed health facilities or pharmacies, stating that many patients in the hospitals were overprescribed antibiotics having a higher risk of bacterial resistance selection.
Read Also:
The NCDC boss raised alarm over the increasing deaths of Nigerians associated with antibiotic resistance due to the abuse of such medications, noting that something should be done urgently to educate Nigerians on the health hazards.
Read Also: Improving The Access To Medical Services In Local Communities
He said this would prevent many infections like cancers, allergies, mutations associated with abusing ARM – antibiotics and antiparasitics from becoming untreatable, hence reducing many deaths.
He urged Nigerians to ensure that they got proper prescriptions on the usage of antibiotics from qualified health professionals before taking them.
He disclosed that AMR, otherwise known as drug resistance and big challenge in Nigeria, was projected to cause over 10 million deaths globally by 2050.
According to him, some identified challenges for Nigeria’s AMR response include suboptimal coordination between relevant sectors, poor surveillance and response on account of limited availability of diagnostics.
Among this are inadequate resources, suboptimal adoption and practice of standardised infection prevention and control practices in the community and health facilities.
He said limited access to proper medications, inappropriate prescription practices and poor enforcement of legal frameworks in place to regulate antimicrobial also pose challenges.
The Technical Officer of AMR at the WHO in Nigeria, Dr Laxmikant Chavan, called on stakeholders to accelerate the AMR response in the country.
